← Back to Search

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

N/A

Recruiting

Research Sponsored by Jewish General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 hours

Awards & highlights

Study Summary

This trial will measure the improvement in lung function in patients with CTEPH before and after a balloon pulmonary angioplasty to open narrowed pulmonary arteries.

Who is the study for?

This trial is for patients with chronic thromboembolic pulmonary hypertension who are candidates for a procedure called balloon pulmonary angioplasty. People taking certain blood pressure medications or those with a heart condition known as patent foramen ovale cannot participate.Check my eligibility

What is being tested?

The study aims to measure the recovery of functional capillary surface area in the lungs of patients undergoing balloon pulmonary angioplasty, which is a treatment to widen narrowed arteries caused by chronic blood clots.See study design

What are the potential side effects?

Since this trial focuses on measuring lung function rather than testing a new drug or medical intervention, there are no direct side effects from the measurement process itself.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Increase in pulmonary functional capillary surface area

Trial Design

1Treatment groups

Experimental Treatment

Group I: Pre and post BPAExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Jewish General HospitalLead Sponsor

137 Previous Clinical Trials

272,004 Total Patients Enrolled

Media Library

Balloon Pulmonary Angioplasty Clinical Trial Eligibility Overview. Trial Name: NCT05719415 — N/A

Pulmonary Hypertension Research Study Groups: Pre and post BPA

Pulmonary Hypertension Clinical Trial 2023: Balloon Pulmonary Angioplasty Highlights & Side Effects. Trial Name: NCT05719415 — N/A

Balloon Pulmonary Angioplasty 2023 Treatment Timeline for Medical Study. Trial Name: NCT05719415 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for this trial restricted to individuals over a certain age?

"According to the criteria for admission, potential participants must be 18 and no older than 75 years of age."

Answered by AI

How many participants are accepted into this medical experiment?

"Affirmative. According to clinicaltrials.gov, this research is recruiting eligible volunteers; the trial was introduced on January 30th 2023 and has been updated since then. The project aims to enlist 40 participants accross a single site."

Answered by AI

Are participants currently being accepted into this clinical trial?

"As seen on clinicaltrials.gov, this study is actively seeking out patients with relevant conditions to participate in the trial. The investigation was first announced on January 30th of 2023 and has been updated since then."

Answered by AI

Who is eligible to enroll in this medical experiment?

"This trial is open to 40 individuals with pulmonary hypertension aged 18-75. To be eligible, patients must have been diagnosed as suitable for balloon pulmonary angioplasty treatment for chronic thromboembolic pulmonary hypertension."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessment of Recovery of Functional Capillary Surface Area in Patients Undergoing a Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Dr David Langleben 2023. "Assessment of Recovery of Functional Capillary Surface Area in Patients Undergoing a Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05719415.

All > Pulmonary Embolism > Pulmonary Hypertension